Ipsen SA (France) Top Management
IPN Stock | EUR 109.40 0.10 0.09% |
Ipsen SA employs about 5 K people. The company is managed by 32 executives with a total tenure of roughly 195 years, averaging almost 6.0 years of service per executive, having 156.25 employees per reported executive. Analysis of Ipsen SA's management performance can provide insight into the company performance.
Richard Paulson CEO Executive Vice President and Chief Executive Officer of Ipsen North America |
David Loew CEO Chief Executive Officer, Director |
Ipsen |
Ipsen SA Management Team Effectiveness
The company has return on total asset (ROA) of 0.1026 % which means that it generated a profit of $0.1026 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1944 %, meaning that it generated $0.1944 on every $100 dollars invested by stockholders. Ipsen SA's management efficiency ratios could be used to measure how well Ipsen SA manages its routine affairs as well as how well it operates its assets and liabilities.Ipsen SA Workforce Comparison
Ipsen SA is currently regarded as number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 144,118. Ipsen SA holds roughly 5,000 in number of employees claiming about 3% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.21 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.28 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.28. Ipsen SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Ipsen SA Price Series Summation is a cross summation of Ipsen SA price series and its benchmark/peer.
Ipsen SA Notable Stakeholders
An Ipsen SA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Ipsen SA often face trade-offs trying to please all of them. Ipsen SA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Ipsen SA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Richard Paulson | Executive Vice President and Chief Executive Officer of Ipsen North America | Profile | |
David Loew | Chief Executive Officer, Director | Profile | |
Aymeric Chatelier | Interim Chief Executive Officer, Chief Financial Officer, Executive Vice President | Profile | |
Marc Garidel | Chairman, CEO and Chairman of Strategic Committee | Profile | |
Antoine Flochel | Vice Chairman of the Board | Profile | |
Francois Garnier | Executive Vice President General Counsel, Member of the Executive Committee | Profile | |
Dominique Bery | Executive Vice President, Strategy and Transformation | Profile | |
Yan Moore | Senior Vice President Head of Oncology Therapeutics Area | Profile | |
Aidan Murphy | Executive Vice-President Technical Operations | Profile | |
Howard Mayer | Executive Vice President, Head of Research & Development | Profile | |
Regis Mulot | Chief Human Resource Officer, Executive Vice President | Profile | |
Alexander McEwan | Vice President and Head of Radiopharmaceuticals | Profile | |
Ivana MagovcevicLiebisch | Executive Vice President Chief Business Officer | Profile | |
Harout Semerjian | Executive Vice President & President Specialty Care International & Global Franchises | Profile | |
Benoit Hennion | Executive Vice President and President Consumer Helathcare | Profile | |
Dominique Laymand | Executive Vice President, Chief Ethics and Compliance Officer | Profile | |
Henri Beaufour | Director | Profile | |
Carol Xueref | Independent Director | Profile | |
Margaret Liu | Independent Director | Profile | |
Philippe Bonhomme | Director, Permanent representative of Beech Tree SA | Profile | |
Michele Ollier | Independent Director | Profile | |
Carol Stuckley | Independent Director | Profile | |
JeanMarc Parant | Director, representing Employees | Profile | |
Anne Beaufour | Director, Permanent representative of Highrock S.àr.l. | Profile | |
Paul Sekhri | Independent Director | Profile | |
Gwenan White | Executive Vice President Communications and Public Affairs | Profile | |
Piet Wigerinck | Independent Director | Profile | |
Craig Marks | VicePres Relations | Profile | |
Yan MD | VP Area | Profile | |
Steven Hildemann | Executive Vice President Chief Medical Officer, Head of Global Medical Affairs and Pharmacovigilance | Profile | |
Philippe LopesFernandes | Executive Vice President Chief Business Officer | Profile | |
Stephan Gagne | Head Office | Profile |
About Ipsen SA Management Performance
The success or failure of an entity such as Ipsen SA often depends on how effective the management is. Ipsen SA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Ipsen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Ipsen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Ipsen S.A. operates as a biopharmaceutical company worldwide. Ipsen S.A. was founded in 1929 and is headquartered in Boulogne-Billancourt, France. IPSEN operates under Drug ManufacturersSpecialty Generic classification in France and is traded on Paris Stock Exchange. It employs 5700 people.
Please note, the presentation of Ipsen SA's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ipsen SA's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ipsen SA's management manipulating its earnings.
Ipsen SA Workforce Analysis
Traditionally, organizations such as Ipsen SA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Ipsen SA within its industry.Ipsen SA Manpower Efficiency
Return on Ipsen SA Manpower
Revenue Per Employee | 631.3K | |
Revenue Per Executive | 98.6M | |
Net Income Per Employee | 118.4K | |
Net Income Per Executive | 18.5M | |
Working Capital Per Employee | 69.6K | |
Working Capital Per Executive | 10.9M |
Complementary Tools for Ipsen Stock analysis
When running Ipsen SA's price analysis, check to measure Ipsen SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ipsen SA is operating at the current time. Most of Ipsen SA's value examination focuses on studying past and present price action to predict the probability of Ipsen SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ipsen SA's price. Additionally, you may evaluate how the addition of Ipsen SA to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |